Arthneeti
All Q2 FY27 results →
AH

Apollo Hospitals Enterprise Ltd

Q2 FY27Healthcare Services

Apollo Hospitals Enterprise Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹8,600
Market cap₹1.2L Cr
P/E58.8
Updated4 Nov 2026
Read3 min read

Get Apollo Hospitals Enterprise Ltd's next results in your feed

Apollo Hospitals Enterprise Ltd Q2 FY27 key numbers

Revenue
Healthcare Services Q2 FY27 Revenue: ₹38,998 million, up 23% YoY.

As stated in Apollo Hospitals Enterprise Ltd's Q2 FY27 investor presentation · published 4 Nov 2026. Reported figures, not investment advice.

Based on Apollo Hospitals Enterprise Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY27 Revenue: ₹76,149 million (Consolidated), up 23% YoY from ₹61,888 million in Q2 FY26. Q2 FY27 Financials (Consolidated).

From Apollo Hospitals Enterprise Ltd's Q2 FY27 earnings-call transcript · updated 4 Nov 2026.

How did Apollo Hospitals Enterprise's revenue grow in the September 2026 quarter?

  • Q2 FY27 Revenue: ₹76,149 million (Consolidated), up 23% YoY from ₹61,888 million in Q2 FY26.
  • Healthcare Services Q2 FY27 Revenue: ₹38,998 million, up 23% YoY.
  • Diagnostics & Retail Health Q2 FY27 Revenue: ₹4,294 million, up 20% YoY.
  • Digital Health & Pharmacy Distribution Q2 FY27 Revenue: ₹32,857 million, up 23% YoY.
  • Healthcare Services Q2 FY27 IP Discharges (volume): 185,980, up 14% YoY from 162,984 in Q2 FY26.
  • Operating Beds increased 6% YoY to 8,522.

2 more points from Apollo Hospitals Enterprise Ltd's call on revenue

Create a free account to keep reading this call

What happened to Apollo Hospitals Enterprise's margins in Q2 FY27?

See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.

What capex is Apollo Hospitals Enterprise planning?

  • Total healthcare services expansion plan includes ~4,718 census beds post expansion (from 9,605 to ~13,800 beds).
  • Total project cost approximately ₹11,150 crore, with ₹7,100 crore balance to be spent.
  • Commissioned 5 new hospitals (~1,000 census beds), of which 520 beds operationalized; remaining 480 beds to be activated over 12–18 months.
  • FY26-FY27 projects (total cost ₹3,185 crs): Pune (384 beds, 305 commissioned, cost ₹665 cr, 125 beds operationalized), Sonarpur Kolkata (270 beds, 220 commissioned, ₹310 cr, 100 beds operationalized), Gachibowli Hyderabad (375 beds, 300 commissioned, ₹550 cr, 155 beds operationalized), Defence Colony Delhi (42 beds, 40 commissioned, ₹65 cr, 40 beds operationalized), Sarjapur-1 Acquisition (180 beds, 150 commissioned, ₹300 cr, 100 beds operationalized), Gurgaon NCR (469 beds, 380 commissioned, ₹1,295 cr).
  • FY28-FY29 projects (estimated ₹575 cr): Jubilee Hills, Secunderabad, Malleswaram & Mysore expansions, Indore Oncology (total 400 beds, 327 commissioned).

2 more points from Apollo Hospitals Enterprise Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Apollo Hospitals Enterprise raising money or cutting debt?

See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Apollo Hospitals Enterprise's order book?

Therefore: - No order inflow numbers are included. The presentation is primarily centered on revenue growth, profitability, segment-wise financials, operational metrics, and Ind AS 116 lease accounting impacts.

Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹7.0K Cr, net profit ₹610 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Apollo Hospitals's management said in earlier quarters

Others in Healthcare Services this season

  • Gujarat Kidney (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,809 lakhs, +195% YoY (Page 6, 7) . Key investor presentation takeaways from Gujarat Kidney & Super Speciality Ltd's Q2 FY27

  • Krishna Institute of Medical Sciences (Q2 FY27)

    13,630 million, up 41.3% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Krishna Institute of Medical Sciences Ltd's Q2 FY27 investor presentation —

  • Vimta Labs (Q2 FY27)

    Export-import linked food testing volumes recovering with operations reaching 60%-70% of normal levels. Key concall takeaways from Vimta Labs Ltd's Q2 FY27…

  • Dr Lal Pathlabs Ltd (Q2 FY27)

    874 Cr, up 19.6% YoY from Rs. Key investor presentation takeaways from Dr Lal Pathlabs Ltd's Q2 FY27 investor presentation — and how it ranks against sector pee

Compare:vs Max Healthcarevs Manipal Healthvs Aster DM Quality Care Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Apollo Hospitals Enterprise Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Apollo Hospitals Enterprise Ltd Q2 FY27 results?

Q2 FY27 Revenue: ₹76,149 million (Consolidated), up 23% YoY from ₹61,888 million in Q2 FY26. Q2 FY27 Financials (Consolidated).

What is Apollo Hospitals Enterprise Ltd share price analysis?

Apollo Hospitals Enterprise Ltd currently shows a neutral. The stock trades at a P/E of 58.8 with a market cap of ₹123,648 Cr. Investors should review the full earnings analysis for detailed insights.

Is Apollo Hospitals Enterprise Ltd planning capital expenditure?

Total healthcare services expansion plan includes ~4,718 census beds post expansion (from 9,605 to ~13,800 beds).

Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.